Systemic Effects of Periodontal Diseases: Focus on Atherosclerosis by Emil Kozarov & John Grbic
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Systemic Effects of Periodontal Diseases: 
Focus on Atherosclerosis 
Emil Kozarov and John Grbic 
Columbia University College of Dental Medicine,  
Section of Oral and Diagnostic Sciences, New York, NY, 
USA 
1. Introduction 
Periodontitis is a bacterially induced, localized, chronic inflammatory disease of 
periodontium that destroys connective tissues and bone supporting the teeth and may lead 
to tooth exfoliation and edentulism. Periodontitis is one of the most prevalent infectious 
diseases in humans. Mild forms affect 30% to 50% of adults and the severe generalized form 
affects 5% to 15% of the US adults (Periodontology, 2005). It is associated with specific 
bacterial groups, components of the dental biofilm, one of them (the “red complex”) closely 
related to clinical measures of periodontal disease (Socransky et al., 1998).  
Periodontal pathogens normally inhabit the oral cavity as constituents of the dental biofilm. 
Since they are in intimate contact with the gingival epithelial tissues, they, however, can 
breach the gingival mucosal barrier at the ulcerative lesion and enter the circulation. Indeed, 
these organisms have been implicated in infections at distant sites, such as the central 
nervous system (Ewald et al., 2006), and measures of periodontitis (tooth loss) has been 
linked to subclinical atherosclerotic vascular disease (carotid artery plaque prevalence) 
(Desvarieux et al., 2003).  
Systemic dissemination can be a result of tissue invasion, or of dental procedures including 
personal oral hygiene, leading to bacteremia. Tissue invasion is very likely a key virulence 
factor for a bacterium since it provides a “privileged niche” (Falkow, 1997) with access to 
host nutritional and iron substrates and a shelter from the host humoral and cellular 
immune response. Intracellular localization also brings about bacterial persistence, critical 
property of a causative agent of a chronic disease.  
Atherosclerosis is a chronic inflammatory focal proliferative lesion of the arteries associated 
with conventional risk factors such as hypercholesterolemia, hypertension, diabetes and 
smoking, in addition to genetic factors (Libby and Theroux, 2005). However, the incidence 
of AS is not fully explained by these risk factors. It is now accepted that inflammation as a 
key integrative process playing a major role in the initiation and progression of 
atherosclerotic lesions, with the active participation of smooth muscle cells, leukocytes, 
growth factors and inflammatory mediators. A dynamic and progressive process, 
atherogenesis begins with endothelial dysfunction (“response to injury” model) that also 
interacts with the standard risk factors (Van Dyke and Kornman, 2008), (Libby et al., 2009).  
Novel diagnostic and treatment modalities targeting vascular inflammation are dependent 
on further investigations of the origins of the inflammation. The focus of this review is the 
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contribution of periodontal pathogens to atherosclerotic inflammations, based on the latest 
communications.  
Inflammation is involved in all stages of the atherosclerosis, from initiation through 
progression and, ultimately, the thrombotic complications (Libby et al., 2002). The role of 
inflammation as a direct causative factor in atherosclerotic vascular disease is intensely 
investigated (Libby et al., 2011). Thus, increased concentrations of high sensitivity C-reactive 
protein (hsCRP) have been shown to predict future acute myocardial infarction (MI) (de 
Beer et al., 1982). hsCRP levels were significantly elevated in 90% in unstable angina pectoris 
patients compared to 13% of stable angina patients; the average CRP values were 
significantly different (p = 0.001) for the unstable angina group (2.2 +/- 2.9 mg/dl) 
compared to the stable angina (0.7 +/- 0.2 mg/dl) groups (normal is less than 0.6 mg/dl) 
(Berk et al., 1990). Further, after adjustment for lipid and non-lipid factors, elevated CRP 
levels were significantly related to an increased risk of coronary heart disease (CHD), with 
relative risk 1.79 [(at CRP levels ≥3.0 mg per liter, as compared with subjects with levels of 
<1.0 mg per liter (95% CI, 1.27 to 2.51; P for trend <0.001)] (Pai et al., 2004). Overall, the 
recognition of inflammatory character of atherosclerosis led to the successful application of 
hsCRP as acute-phase marker for cardiovascular risk assessment (Libby et al., 2010). 
 
 
Fig. 1. Simplified chart representing the response to injury model of infectious agents-
induced initiation and progression of the atherogenesis. Inflammation drives the initiation, 
progression, and eventually, the rupture of atherosclerotic plaques. The process involves 
inflammatory mediators and innate and adaptive immunity. A constant or repetitive injury 
may ultimately lead to necrosis, plaque rupture, myocardial infarction (MI) or stroke.  
Pathogen burden. Since the incidence of atherosclerosis is only partially explained by the 
accepted risk factors, the attention was turned to infections as a potential cause of AS, 
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focusing on the total infectious burden (Ridker, 2002), (Epstein et al., 2009). The accumulated 
evidence suggests that the aggregate burden of the chronic infections, rather than a single 
pathogen, may contribute to increased risk of AS and clinical vascular events (Elkind, 2010). 
Indeed, an abundance of epidemiological evidence is presented in support of this notion 
(Ross, 1999), (Libby et al., 2002), and particularly in respect to periodontal infections 
[Desvarieux, 2005 #2905], (Demmer and Desvarieux, 2006), (Kebschull et al., 2010). The 
pathogen-initiated inflammatory process leading to endothelial cell activation, leukocyte 
rolling, adhesion and diapedesis, growth factor release, smooth muscle cell (SMC) 
proliferation and foam cell formation (Libby et al., 2010) all form the basis of the “response 
to injury” model of atherogenesis (Fig. 1).  
Periodontitis as a risk factor for adverse ischemic events. Epidemiological and 
seroepidemiological studies addressed the association between these conditions relatively 
recently. The first epidemiological association was found between dental health and acute 
myocardial infarction (MI), where the former was significantly worse in 100 patients with 
MI than in 102 controls after adjustment for age, social class, smoking, serum lipid 
concentrations, and the presence of diabetes (Mattila et al., 1989). The results from the Oral 
Infections and Vascular Disease Epidemiology Study (INVEST) of 657 subjects with no 
history of stroke or myocardial infarction indicated that chronic infections, including 
periodontitis, may predispose to cardiovascular disease (CVD) (Desvarieux et al., 2005). In 
that study, mean carotid artery intima-media thickness (IMT) was related to the total 
bacterial burden, the periodontal bacterial burden, and to the relative predominance of 
periodontal over other bacteria in the subgingival plaque. After adjustments for age, 
race/ethnicity, gender, education, body mass index, smoking, diabetes, systolic blood 
pressure, and LDL and HDL cholesterol, it was demonstrated that periodontal bacterial 
burden was related to the carotid IMT, a measure of subclinical atherosclerosis (P=0.002). In 
other investigations, using a multivariate logistic regression model, periodontal bone loss 
was associated with a ~ 4-fold increase in risk for carotid atherosclerosis (adjusted OR, 3.64; 
CI, 1.37 to 9.65) (Engebretson et al., 2005) and edentulousness was independently associated 
with the risk of aortic stenosis in a cohort of 2341 individuals (Volzke et al., 2005). 
Using seroepidemiology, a study of 572 patients showed that the extent of atherosclerosis 
(using coronary angiography, carotid duplex sonography, and ankle-arm index) and CVD 
mortality were associated with elevated IgA and IgG titers to infectious agents. After 
adjustment for age, sex, classical risk factors and high hsCRP, infectious burden was 
significantly associated with advanced atherosclerosis, with an odds ratio (95% CI) of 1.8 
(1.2 to 2.6) for 4 to 5 seropositivities (P<0.01) and 2.5 (1.2 to 5.1) for 6 to 8 seropositivities 
(P<0.02) (Espinola-Klein et al., 2002). Elevated levels of he periodontal patrhogens 
Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans – specific serum IgG were 
associated with atherosclerosis (Colhoun et al., 2008). Interestingly, IgM antibodies specific 
for phosphorylcholine (PC), hapten-like epitope found on oxLDL and also on bacteria are 
atheroprotective; low PC-antibody titers are associated with an increased risk for CVD 
(Frostegard, 2010). Recently, in a study of 313 cases and 747 controls, using 
immunofluorescence microscopy and species-specific antibodies, the presence of  
six periodontal pathogens, P. gingivalis, Tannerella forsythensis, Prevotella intermedia, 
Campylobacter recta, Fusobacterium nucleatum, and Eubacterium saburreum, and their co-
occurrence (0-6) was compared with the odds of having MI. Suggesting a role for a total 
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periodontal microbial burden, subjects with ≥ 3 periodontal pathogens species had about 2-
fold increase in odds of having nonfatal MI than those who did not have any type of 
bacterial species [OR = 2.01 (1.31-3.08)], also suggesting that specifically the presence of T. 
forsythensis and P. intermedia was associated with increased odds of having MI (Andriankaja 
et al., 2011).  
Interestingly, there is some noticeable discrepancy between the effects of periodontal 
infections on MI compared to ischemic stroke, even within the same populations and 
databases. While one such investigation found stronger association of periodontitis with 
stroke than with CHD (hazard rate 3.52; 95% confidence interval [CI], 1.59-7.81) (Jimenez 
et al., 2009), another study of 8032 subjects did not find “convincing evidence of a causal 
association between periodontal disease and CHD risk” (Hujoel et al., 2000). Still, using 
data from a total of 10,146 participants from the Third National Health and Nutrition 
Examination Survey (1988-1994), the link between periodontal health (gingival bleeding 
index, calculus index, and periodontal disease status, defined by pocket depth and 
attachment loss) and CVD risk factors (serum total and high density lipoprotein 
cholesterol, C-reactive protein, and plasma fibrinogen) was examined, showing a 
significant relation between indicators of poor periodontal status and increased CRP (Wu 
et al., 2000). 
The results from these investigations vary significantly for variety of reasons, such as 
variations in study populations, differing measures - clinical (such as pocket depth and 
bleeding on probing) - and non-clinical (systemic antibody response or alveolar bone loss 
radiography) of periodontitis. These discrepancies suggest confounding factors common for 
periodontitis and CVD such as smoking that would interfere with the association between 
the conditions (Hujoel, 2002). Therefore, specific studies using multivariate and stratified 
analyses have been designed to address the confounding (Demmer and Desvarieux, 2006) 
and few meta-analyses have been published. One such analysis of PubMed, Cochrane 
Controlled Trials Register, EMBASE, and SCOPUS databases for references on periodontitis 
and CVD showed strong association between them, with a summary odds ratio of 1.75 (95% 
confidence interval (CI): 1.32 to 2.34; P <0.001), compared to periodontally healthy subjects 
(Mustapha et al., 2007). Another meta-analysis of seven cohort studies supported the 
association and shows that periodontitis is a risk factor or marker for CHD, independent of 
traditional risk factors (Humphrey et al., 2008). Taken together, the epidemiological and 
seroepidemiological data suggest further investigation of the periodontal component of 
CVD.  
Bacteremia. Since there are 108 – 1012 bacteria found per diseased periodontal site, large 
numbers of oral bacterial species, including periodontal can enter the circulation through 
the microvasculature following tooth brushing and other dental procedures (Iwai, 2009). 
Using PCR, hematogenous spread of bacteria was demonstrated in blood samples taken 
from 30 patients after ultrasonic scaling, periodontal probing and tooth brushing at 23%, 
16% and 13% of the patients, respectively (Kinane et al., 2005). Further supporting the notion 
that periodontal organisms gain access to the circulation during dental hygiene procedures, 
another investigation of 194 patients demonstrated that periodontal site bleeding after tooth 
brushing was associated with ~8-fold increase in bacteremia (Lockhart et al., 2009). Unlike 
the clinical measures of periodontitis, the bleeding on probing was more associated with 
systemic inflammation than attachment loss (Beck and Offenbacher, 2002) and most 
associated with bacteremia (Lockhart et al., 2009). 
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2. Periodontal pathogen-accelerated endothelial injury and atherogenesis 
The “response to injury” hypothesis presents atherosclerosis as an inflammatory disease, 
bearing similarity to a bacterial infection where the innate and adaptive arms of the immune 
systems are involved. In addition to the initiation and progression of the atheromas, 
inflammation is also related to the end stage of the disease, characterized by plaque rupture, 
atherothrombosis and acute ischemic events (Libby, 2007).  
Several plausible models have emerged focusing on the pro-atherogenic mechanisms of 
action of periodontal pathogens. The immune response to periodontitis that may contribute 
to atherogenesis via pro-atherogenic systemic inflammatory response (immunological 
sounding) and autorecognition (autoimmunity, molecular mimicry) has been thoroughly 
reviewed elsewhere (Gibson et al., 2008), (Hayashi et al., 2010), (Teles and Wang, 2011).  
Microbial invasion and its sequelae. In addition to immunological mechanisms, there are 
two metastatic avenues that periodontal organisms can exploit to reach vascular endothelia, 
direct invasion as a consequence of bacteremia and dissemination via internalization in 
migrating phagocytic cells (the “Trojan horse” approach).  
Direct invasion. Periodontal bacteria have evolved elaborate strategies to invade non-
professional phagocytes. Invasion of host cells is very likely a key virulence mechanism for a 
bacterium since intracellular residence provides “privileged niche” with 1) a nutrient-rich 
reducing environment with access to host protein and iron substrates, 2) partial protection 
from dental hygiene procedures including scaling and root planing (Johnson et al., 2008), 3) 
sequestration from the humoral and cellular immune responses, crucial at early stages of 
infection, 4) a means for replication and persistence that provides a reservoir and is essential 
for a chronic disease, and 5) protection from drug treatment (Eick and Pfister, 2004). Most 
available information regarding the invasive ability of periodontopathic bacteria concerns P. 
gingivalis [Lamont, 1995 #1268], (Dorn et al., 2001) and A. actinomycetemcomitans (Fives-
Taylor et al., 1999), (Tomich et al., 2007). Eikenella corrodens and Prevotella intermedia were 
also shown to invade human primary endothelial and SM cells (Dorn et al., 1999). 
Collectively, it appears that the intracellular localization is a viable option for variety of 
periodontal pathogens (Tribble and Lamont, 2010).  
Dissemination via internalization in migrating phagocytic cells (the “Trojan horse” 
approach). Unlike direct bacteremic dissemination, where bacteria spread in the circulation 
subject to opsonization and clearing by the humoral and cellular immune response, bacteria 
can metastasize after internalization in monocytes/macrophages or in dendritic cells (DCs) 
at the diseased site. Using such a “Trojan horse” approach, pathogens are able to 
disseminate and gain reach of endothelia, where due to extravasation of the carrier 
phagocytes they can localize at the activated endothelium in the arterial wall. A recently 
proposed model describes how P. gingivalis may exploit DCs to spread from the oral sites 
and gain access to systemic circulation. Thus, P. gingivalis may contribute to atherogenesis 
via subverting normal DC function, promoting a semimature, highly migratory, and 
immunosuppressive DC phenotype that contributes to the inflammatory development of 
atherosclerosis and, eventually, to plaque rupture (Zeituni et al., 2010). Supporting this 
suggestion, the infection with invasive P. gingivalis strain was shown to induce monocyte 
migration and significantly enhance the production of the pro-inflammatory cytokines 
(Pollreisz et al., 2010).  
Bacterial transmission between vascular endothelial and smooth muscle cells. In the only 
thorough investigation of P. gingivalis invasion of primary human endothelial and SM cells, 
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it was shown that the organism can spread intercellularly in vascular cell types (Li et al., 
2008). This property has been previously demonstrated with a monoculture of gingival 
epithelial cells (Yilmaz et al., 2006). Using vascular cell cultures and immunofluorescence, 
the study demonstrates that bacteria can transmit between the same as well as between 
different cell types, from infected to fresh cells, leading to spreading of the infection that in 
clinical setting could lead to chronicity of disease (Li et al., 2008). 
2.1 Proatherogenic consequences of bacterial presence in vascular cells 
Activation of endothelial and smooth muscle cells. Endothelial cell activation is a pivotal 
moment in initiation of atherogenesis. It was shown that infection with P. gingivalis, but not 
with non-invasive non-fimbriated mutant induced the expression of intercellular adhesion 
molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1) and P- and E-selectins in 
human endothelial cells (Khlgatian et al., 2002). Further, it was shown that P. gingivalis 
fimbria elicit chemokine production in human aortic endothelial cells via actin cytoskeletal 
rearrangements and that the pro-inflammatory IL-1β, IL-8 and MCP-1 were induced in these 
cells (Takahashi et al., 2006). P. gingivalis infection activates host cells via TLR2 and TLR4 - 
mediated cell signaling (Hajishengallis et al., 2006), (Hayashi et al., 2010). 
The smooth muscle cells (SMC) were found to respond to bacteria in a prothrombotic or in a 
proliferative manner (Roth et al., 2009), (Wada and Kamisaki, 2010). In the latter 
communication, it was shown that SMC proliferation in distal aorta aneurysms was 
associated with presence of P. gingivalis in the dental plaque of the patients.  
Prothrombotic effects of bacteria and plaque rupture. An alternative mechanism through 
which bacteremias (or bacteria present in ruptured plaque) may contribute to vascular 
thrombosis is the triggering of the coagulation cascade (Herzberg et al., 2005), (Iwai, 2009). 
The potential adverse role of bacteria in atherothrombosis has been shown using human 
aortic SMC. Live invasive P. gingivalis, but not heat-killed or non-invasive mutant 
specifically suppressed tissue factor pathway inhibitor (TFPI) produced by vascular cells. 
The results suggested a procoagulant response of the host cells to bacteria (Roth et al., 
2009).Plaque rupture, leading to exposure of the prothrombotic plaque core to the 
circulation and thrombus formation can be attributed to bacteria-dependent release of 
metalloproteinases (MMPs) with concomitant suppression of the MMP antagonist, tissue 
inhibitor of MMPs (TIMP) (Sato et al., 2009), (Guan et al., 2009).  
Animal models furnish a useful research tool and are indispensable in testing hypotheses at 
a pre-clinical stage (Graves et al., 2008). In a study of wild-type P. gingivalis and a non-
invasive FimA- mutant, both strains were detected in blood and aortic tissue of ApoE-/- mice 
by PCR after challenge, however only the invasive strain accelerated atherosclerosis in the 
animal model [Gibson, 2004 #2679]. Importantly, a prevention of P. gingivalis-accelerated 
atherosclerosis via immunization to control P. gingivalis-elicited periodontitis was 
demonstrated in the same study. Furthermore, using a mouse model of atherosclerosis and 
metronidazole administration followed by P. gingivalis i.v. inoculation, it was shown that 1) 
the lack of invasion ability of the mutant prevents the formation of aortic lesions in the 
animals inoculated with fimbriae-deficient strain (DPG3) compared to wild-type strain 
(381), and that 2) metronidazole, common antibacterial used in anaerobic periodontal 
infections, completely prevents the formation of P. gingivalis – associated arterial lesions 
(Amar et al., 2009). The results indicate that this oral pathogen can exert a critical damage on 
the vessels, and that drugs are viable treatment options. It further suggests that the bacterial 
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- endothelia interaction and activation causing phagocyte recruitment to the infection site 
may represent a key step in atherogenesis.  
In addition, rabbit model with experimentally induced periodontitis developed fatty streaks 
in the aorta faster than in periodontally healthy animals, suggesting direct contribution of 
periodontitis to atherosclerosis (Jain et al., 2003) and recurrent P. gingivalis bacteremia 
induced aortic and coronary lesions in normocholesterolemic pigs and increases 
atherosclerosis in hypercholesterolemic pigs (Brodala et al., 2005). Altogether, variety of 
animal models have been used to demonstrate the adverse effect of periodontal bacteria on 
vascular health.  
3. Association of periodontal bacteria with atheromata: Are we finally having 
“the smoking gun”?  
Bacterial fingerprints in atheromas. As outlined above, there is strong evidence that oral 
bacteria can spread in the circulation during dental procedures such as tooth brushing 
(Lockhart et al., 2009). Since more than 700 bacterial species are identified in the mouth 
(Dewhirst et al., 2010), (Parahitiyawa et al., 2010), it is expected that many species, including 
P. gingivalis are disseminated to large vessels. Identification of the pathogens associated with 
atherosclerotic lesions can be performed using PCR and metagenomic approaches. Indeed, 
DNA from periodontal organisms, including A. actinomycetemcomitans and P. gingivalis were 
detected in atheromas by PCR [Haraszthy, 2000 #2237]. Using 16S rDNA PCR, it was also 
found that 1.5-2.2% of the total DNA in the atheromatous samples was bacterial, where 
large proportion of it was of oral origin, especially in the elderly group of individuals (mean 
age, 67 years). P. gingivalis was reported to be the most represented among the 10 species 
tested in this study (Kozarov et al., 2006), which is in line with its invasive properties 
described above (Dorn et al., 1999). It was also expected, since severe periodontal diseases (≥ 
4 mm attachment loss) increase in prevalence with age (approximately 50% of 55-64 years 
old individuals have severe disease), and this is the age with the highest incidence of acute 
ischemic events. 
Using clone libraries, in a comprehensive 16S rDNA PCR signatures study of atherosclerotic 
tissue from 38 CHD patients and 26 controls, bacterial DNA was found only in (all) CHD 
patients but not in controls. Presence of bacteria was confirmed by fluorescence in situ 
hybridization. A bacterial diversity of >50 different species was demonstrated, with a high 
mean bacterial diversity in atheromas, 12.33 +/- 3.81 (range, 5 to 22) (Ott et al., 2006).The 
broad spectrum of bacterial signatures encompassed species from the human barrier organs, 
the skin and the oral cavity. 
Focus on causality. Cardiovascular disease is the leading cause of death and disability in 
industrialized countries. Although bacterial DNA has been recovered from atheromatous 
lesions and a link between inflammatory burden and atherogenesis has been established, 
there has been limited evidence that bacterial agents can be cultivated from atheromatous 
lesions. However, to fulfill Koch's postulate for infectious disease and to provide 
mechanistic data linking infectious agents to CVD, the cultivation of microorganisms from 
atheromatous tissue must be demonstrated. 
Such cultivation has been eluding the biomedical community for decades. As a result (with 
the exception of Chlamydophila pneumoniae), clinical strains could not be cultivated to 
provide key mechanistic link (Fiehn et al., 2005).  
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After viable P. gingivalis and A. actinomycetemcomitans in atheromatous vascular tissue were 
detected for the first time [Kozarov, 2005 #2700], bacterial transmission between primary 
vascular cell types was shown (Li et al., 2008) and finally, periodontal organisms including 
Propionibacteruim acnes, Staphylococcus epidermidis, Streptococcus infantis and P. gingivalis were 
recently cultivated from atheromatous tissue (Rafferty et al., 2011). In addition to P. 
gingivalis, a major periodontal pathogen, the identified species are no strangers to inflamed 
periodontium. P. acnes has been recovered from root canals and from blood samples taken 
during and after endodontic treatment (Debelian et al., 1998) and is the most prevalent 
species in apical periodontitis (Fujii et al., 2009). Importantly, using multivariable regression 
models, it has been shown that among patients with 25 or more teeth, those with two or 
more endodontic therapies had 1.62 times the odds (95% CI, 1.04-2.53) of prevalent coronary 
disease compared with those reporting never having had endodontic therapy (Caplan et al., 
2009). Staphylococcus or Streptococcus, found in the oral cavity, are also detected in other 
systemic infections, in prosthetic valve endocarditis (Nataloni et al., 2010) and in heart 
valves and atheromas, respectively (Nakano et al., 2006), (Kozarov et al., 2006).  
4. Atherosclerosis microbiome, the latest and most critical segment of the 
human microbiome may have a large periodontal component 
Impact of genomics. Although multiple human microbiome projects have been launched, 
genomic studies of the atherosclerosis microbiome have not been initiated. Of note, out of 
1,843 microbial genomes funded by the Human Microbiome Project by July 2011 
(http://www.hmpdacc-resources.org/cgi-bin/hmp_catalog/main.cgi), none are associated 
with atherosclerosis. For comparison, 464 GI tract genomes have been selected for sequencing. 
A project targeting vascular inflammation-associated bacterial pathogens (the atherosclerosis 
microbiome) is conspicuously missing. This is simply due to the inability, until now, of the 
researchers to recover clinical isolates from diseased vascular tissue. Importantly, this segment 
of the human microbiome may represent a subset of the oral (and, possibly, gut) microbiome.  
Focus on viable microbes. Identification of viable bacterial pathogens, members of the 
atherosclerosis microbiome, associated with human atheromatous tissue is critical for 
complete clarification of the potential for infectious etiologies of atherosclerosis and for 
reconsidering application of antibacterials in CVD treatment trials. Using a cellular 
immunology approach (Rafferty et al., 2011) allowing for cultivation of heretofore 
“uncultivable” bacteria from atheromatous tissue of vascular surgery patients, the 
community is now for the first time in a position to comprehensively address the bacterial 
component in vascular inflammations, the atherosclerosis microbiome.  
With this approach, the identification of DNA from dead bacteria will be eliminated and 
only bona fide live organisms will be identified and investigated as the most likely targets for 
association with disease. The approach currently used, PCR of total atheroma DNA with 
species-specific primers or with universal primers followed by cloning of the amplification 
products and sequencing the resulting plasmid libraries (Ott et al., 2006) generates a large 
number of hits and is inconclusive. Bacterial DNA presence in the atheromata may be due to 
macrophages carrying their refuse, phagocytized bacteria from distant sites of the body, 
leading to many 16S rDNA bacterial signatures that may be false positives. The recovered 
by Rafferty et el isolates belong to four species only, both anaerobic and facultative. This 
approach will significantly decrease the complexity of the problem of false positives and 
obviate the need for investing in expensive or newly designed methods and equipment such 
as isolating a single bacterial cell from a specimen and sequencing its chromosome. 
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MN, monocyte. MΦ, macrophage with internalized bacteria. EC, endothelial cell. SMC, smooth muscle 
cell. A, apoptotic endothelial cell releasing intracellular bacteria. 
Fig. 2. Bacterial infection-mediated model of atherogenesis presenting a bacteremic and 
macrophage-mediated tissue infection. Depicted are the tunica intima, a monolayer of 
endothelial cells (ECs) over a basal lamina that contains SMCs and the tunica media 
containing SMCs. Represented at left is the bacteremic microbial invasion of ECs. Within 24-
72 hours the invading intracellular bacteria turn into non-cultivable state (in green). 
Endothelial activation is represented as release in the vascular lumen of proinflammatory 
mediators such as MCP-1. They activate circulating monocytes (MN) and macrophages 
(MΦ), promote their local adhesion and diapedesis into the lesion (in the center). MΦ can 
carry internalized persisting bacteria, thus contributing to the bacterial spreading. The 
activation of non-cultivable bacteria during vascular cell-cell transmission and the spreading 
of infection to adjacent ECs is and to SMCs is shown at right and left. Additional bacteria are 
released in the atherosclerotic core following apoptosis and necrosis of host cells (at right). 
The phagocytosis of bacteria by a monocyte maturating into macrophage and the activation 
of dormant non-cultivable bacteria into active invasive stage (resuscitation, from green to 
red), following their ingestion is shown in the center. Growth factors released from the 
phagocytes promote SMC proliferation and migration (neointimal formation). For clarity, 
vasa vasorum neovascularization, lipids, foam cell formation, plaque rupture and blood 
coagulation/thrombus formation are not presented.  
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5. The heart of the matter: Current model of bacterial infection-accelerated 
atherogenesis, plaque rupture and acute ischemic events 
A model of atherogenesis now emerges where (periodontal) bacteria invade endothelia 
either directly, following bacteremia, or are carried by phagocytes migrating from the 
primary infection site (the “Trojan horse” approach) (Figure 2). Upon invasion of 
endothelial cells, bacterial pathogens such as P. gingivalis are able to reside intracellularly for 
extended period of time, activating the endothelia and initiating the atherogenic process. 
Within 24-72 hours however, in order to sustain and persist, the bacteria switch into a 
dormant uncultivable stage (Li et al., 2008). Still facing a hostile environment 
(phagolysosomal fusion), some bacteria escape from the dormant stage, exiting into 
intracellular space and invading adjacent host cells, becoming transiently invasive and 
cultivable, and perpetuating persistent low-grade inflammation. The return to cultivable 
state specifically can occur after internalization by phagocytes (Rafferty et al., 2011). This 
leads to additional metastatic dissemination, injurious response, apoptosis and necrosis that 
are hallmarks of a chronic disease. Importantly, dormant bacteria have low metabolic 
activity, therefore targets for antibiotics are lacking and the organisms can become drug-
tolerant. Using such mechanism, intracellular pathogens residing in atheromas could control 
their population yet allow for the observed persistent infection. 
In conclusion, the epidemiological and seroepidemiological analyses, the in vitro and in 
vivo investigations, the presence in atheromata of live bacteria, some of them unique for 
periodontal lesions, and the clinical trials conducted so far, largely defend the argument that 
periodontal infections can be an exacerbating component of vascular inflammations. The 
latest data presented here expand the existing model of infectious component of 
atherosclerosis, identifying for the first time possible members of atherosclerosis 
microbiome, suggesting a novel mechanism for bacterial persistence in diseased tissue and 
for recurrence of disease and possibly explaining the failure of antibiotics to ameliorate the 
outcome after treatment of cardiovascular disease patients.  
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